Immunotherapy startup Umoja lands $210M, less than a year after raising $53M
GeekWire
JUNE 18, 2021
Umoja launched in 2019 and is working to commercialize technology developed at Seattle Children’s Research Institute and Purdue University. The strategy also uses a system of tagging cancer cells. The company is developing immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients.
Let's personalize your content